AP
ANL

Antipodes Partners’s Adlai Nortye ANL Stock Holding History

Antipodes Partners’s Portfolio ANL Stock Details ANL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.9K Sell
1,642
-409
-20% -$4.98K ﹤0.01% 127
2026
Q1 		$14.2K Buy
+2,051
New +$13.7K ﹤0.01% 126

Other funds holding ANL

ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Antipodes Partners's ANL Position: Q2 2026 in Review

Antipodes Partners reduced its Adlai Nortye (ANL) stake by 20% in Q2 2026, selling an estimated $4.98K and leaving 1,642 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #127.

Antipodes Partners first reported a position in ANL in Q1 2026 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold ANL as of Q2 2026.

  • Antipodes Partners held 1,642 shares of Adlai Nortye worth $18.9K as of Q2 2026.
  • Antipodes Partners sold 409 Adlai Nortye shares in Q2 2026, an estimated $4.98K.
  • Adlai Nortye made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #127 holding.
  • Antipodes Partners first reported a position in Adlai Nortye in Q1 2026 and has held it in 2 quarters since.
  • 5 funds tracked by Wall St. Rank held Adlai Nortye as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.